Clinical trial Recruiting at 7 sites Phase 4 Interventional Ages 18 to 75

Oliceridine PCIA for Postoperative Pain After VATS Lung Resection

Official title: Effect of Oliceridine-based Intravenous Patient-Controlled Analgesia on Chronic Postsurgical Pain After Video-Assisted Thoracoscopic Lung Resection: A Multicenter Randomized Double-Blind Controlled Trial Protocol

Run by Tianjin Medical University General Hospital · NCT07018375 · Data updated 2026-11-12

This trial tests whether oliceridine given through patient-controlled IV analgesia reduces the risk of chronic pain after lung surgery done with video-assisted techniques, compared with sufentanil.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment320 (estimated)
SponsorTianjin Medical University General Hospital
Academic / other
Drugs / interventionschemotherapy
Locations7 sites (Baoding, Hebei and 6 other locations)
StatusRecruiting
StartedJanuary 6, 2026
Main results expectedMarch 31, 2027
Study endsApril 30, 2027
Registry record updatedSeptember 1, 2026
Trial IDNCT07018375 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18-75 with ASA I-III undergoing unilateral VATS lung resection, without prior chronic pain or long-term analgesic use, and able to provide informed consent.

Probably not a fit

Patients with preexisting chronic pain, prior ipsilateral thoracic surgery, or significant hepatic/renal dysfunction may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a multicenter, randomized, double-blind study comparing oliceridine to sufentanil for perioperative pain control in adults undergoing unilateral VATS lung resection. The goal is to see if using oliceridine reduces the development of chronic postsurgical pain with functional impact. Approximately 320 participants will be enrolled across seven tertiary centers in China. Analgesia is delivered via patient-controlled intravenous analgesia, and outcome measures include the incidence and functional consequences of CPSP. The trial is designed to generate evidence on whether oliceridine offers advantages over sufentanil in this surgical context.

Why it matters

Potential benefit: If successful, patients might experience less chronic pain and better functional outcomes after VATS lung surgery.

How similar studies have gone: Previous research in similar analgesia approaches has shown promise in shaping postoperative pain trajectories, though this exact comparison with oliceridine for CPSP is a relatively novel setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18-75 years
* ASA physical status I-III
* BMI 18-35 kg/m²
* Scheduled for unilateral video-assisted thoracoscopic surgery (VATS) lung resection, including wedge resection, segmentectomy, lobectomy, or radical resection for lung cancerresection for lung cancer
* Preoperative Numeric Rating Scale (NRS) pain score of 0
* Ability to understand the study objectives and procedures, with voluntary informed consent obtained
* Expected postoperative recovery in the general ward setting

Exclusion Criteria:

* History of chronic pain or long-term analgesic use prior to surgery
* Previous ipsilateral thoracic surgery
* Prior neoadjuvant radiotherapy or chemotherapy
* Severe cardiovascular or cerebrovascular disease, or hepatic/renal dysfunction (ALT/AST \> 3 × upper limit of normal; eGFR \< 60 mL/min/1.73 m²)
* Severe or unstable psychiatric disorders requiring psychoactive medication (e.g., schizophrenia, bipolar disorder), or cognitive impairment precluding reliable self-report
* Other concurrent active malignancy or active infection
* Known hypersensitivity to study medications (opioids, adjuvant analgesics, anesthetics, or antiemetics)
* Pregnancy, lactation, or planned pregnancy during the study period
* Participation in another interventional clinical trial within 3 months before enrolment
* Any condition deemed unsuitable for study participation by the investigator

Where it's running

  • The No. 2 Hospital of Baoding
    Baoding, Hebei, China
    Recruiting
  • North China University of Science and Technology Affiliated Hospital
    Tangshan, Hebei, China
    Recruiting
  • Tianjin Medical University General Hospital
    Tianjin, China
    Recruiting
  • Haibin People's Hospital of Tianjin Binhai New Area
    Tianjin, China
    Recruiting
  • The People's Hospital of Jizhou District, Tianjin
    Tianjin, China
    Recruiting
  • The Second Hospital of Tianjin Medical University
    Tianjin, China
    Recruiting
Show 1 more location
  • Tianjin Cancer Hospital Airport Hospital
    Tianjin, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.